Cresco Labs (CRLBF) Operating Income (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Operating Income came in at $11.2 million in Q1 2026, down 17.78% YoY from $13.6 million in Q1 2025, and up 114.79% on a QoQ basis from -$75.5 million in Q4 2025.
Cresco Labs (CRLBF) Operating Income (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Operating Income data on file, last reported at $11.2 million in Q1 2026.
- Quarterly Operating Income fell 17.78% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.4 million (down 133.15% YoY) and the FY2025 annual result came in at -$28.0 million, down 126.08% from the prior year.
- Operating Income rose to $11.2 million in Q1 2026, from -$75.5 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $32.4 million in Q2 2024 to a low of -$143.5 million in Q4 2022.
- A 5-year average of -$4.8 million and a median of $16.2 million in 2022 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income sank 1022.28% — and 2024, when it surged 713.25%.
- Tracing CRLBF's Operating Income over 5 years: stood at -$143.5 million in 2022, then surged by 118.89% to $27.1 million in 2023, then slipped by 28.39% to $19.4 million in 2024, then sank by 489.29% to -$75.5 million in 2025, then surged by 114.79% to $11.2 million in 2026.
- The last three Operating Income figures came in at $11.2 million (Q1 2026), -$75.5 million (Q4 2025), and $17.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Cresco Labs | 297.83 Mn | 233.72 Mn | 86.95 Mn | 13.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.17 Mn |
| Dec 31, 2025 | -75.55 Mn |
| Sep 30, 2025 | 17.83 Mn |
| Jun 30, 2025 | 16.14 Mn |
| Mar 31, 2025 | 13.59 Mn |
| Dec 31, 2024 | 19.41 Mn |
| Sep 30, 2024 | 26.34 Mn |
| Jun 30, 2024 | 32.38 Mn |
| Mar 31, 2024 | 29.16 Mn |
| Dec 31, 2023 | 27.10 Mn |
| Sep 30, 2023 | -107.76 Mn |
| Jun 30, 2023 | -10.75 Mn |
| Mar 31, 2023 | 3.59 Mn |
| Dec 31, 2022 | -143.48 Mn |
| Sep 30, 2022 | 16.24 Mn |
| Jun 30, 2022 | 22.68 Mn |
| Mar 31, 2022 | 20.27 Mn |
| Dec 31, 2021 | 15.56 Mn |
| Sep 30, 2021 | -264.02 Mn |
| Jun 30, 2021 | 14.87 Mn |